The Rai Binet Medal
The Rai Binet Medal is awarded in recognition to outstanding contribution to CLL research and is presented at the iwCLL Biennial Meeting. It is named after the two recipients, Kanti Rai and Jacques-Louis Binet.
2019 Edinburgh, UK
Hartmut Döhner – for the hierarchical classification and clinical correlation of fluorescence in-situ hybridization (FISH) for cytogenetic abnormalities in CLL.
2017 New York, USA
John Gribben – Work on restricted CLL antigens, tumor microenvironment, and leadership in bone marrow/stem cell transplantation.
Peter Hillmen – Work on the UK CLL trials, monoclonal B cell lymphocytosis (MBL) and minimal residual disease (MRD), and paroxysmal nocturnal hemoglobinuria.
2015 Sydney, Australia
Freda Stevenson – For identifying the correlation of CLL IGVH with stages of normal B lymphocyte maturation and the robust correlation of IGVH mutational status as a robust prognostic marker in CLL.
Federico Caligaris-Cappio – Work on CD5+ B cells, speculating that these were precursors of CLL, and identifying the phenotype, genotype, and function of anergic B cell clones in CLL.
2013 Cologne, Germany
Thomas Kipps – Founder and PI of the CLL Research Consortium and for outstanding contribution to CLL.
Michael Hallek – Founder of the German CLL Study Group and for outstanding contribution to CLL.
2011 Houston, USA
Guillermo Dighiero – In recognition of his life-long work in the French CLL trials and for his insight into the biology of the B cell receptor (BCR).
2009 Barcelona, Spain
Emili Montserrat – Work on prognostic factors and stem cell transplantation.
2007 London, UK
Carlo Croce – Discovery of the miR genes 15, 16 genes at MDR 13q14 and TCL-1 mouse model of the disease.
David Galton (post humously) – For his work on the natural history of CLL and introduction of chlorambucil.
2005 New York, USA
Daniel Catovsky – Work on the morphology of CLL and the Medical Research Council (MRC) trials.
2003 Stresa, Italy
Nick Chiorazzi and Terry Hamblin – Discovery of the importance of VH mutational status.
2002 San Diego, USA
Michael Keating – Early and continuing work with fludarabine.
1999 Paris, France
Jacques-Louis Binet and Kanti Rai – Description of the early CLL staging systems.